Inhibitory effects of polymyxin B on NF-κB activation and expression of procollagen I, III in pre-eclamptic umbilical artery smooth muscle cells

Chinese Medical Journal

Volumn 119, Issue 5, 2006, Pages 384-390

  Jiang, Rong Zhen ^a   Chen, Han Ping ^b   Xu, Xiao Yan ^b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

NF B; Polymyxin B; Pre eclampsia

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CYTOKINE; DNA; GROWTH FACTOR; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; POLYMYXIN B; PROCOLLAGEN; PROTEIN KINASE C INHIBITOR; COLLAGEN TYPE 1; COLLAGEN TYPE 3; PROTEIN KINASE C;

ANALYSIS OF VARIANCE; ARTERY MUSCLE; ARTICLE; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS; DRUG MECHANISM; FEMALE; FLOW CYTOMETRY; GENE ACTIVATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INCUBATION TIME; MITOSIS; PATHOGENESIS; PHENOTYPE; PLACENTA; PREECLAMPSIA; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERUM; SIGNAL TRANSDUCTION; UMBILICAL ARTERY; CELL CULTURE; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; PREGNANCY; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

CELL CYCLE; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN TYPE I; COLLAGEN TYPE III; FEMALE; HUMANS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NF-KAPPA B; POLYMYXIN B; PRE-ECLAMPSIA; PREGNANCY; PROTEIN KINASE C; RNA, MESSENGER; SIGNAL TRANSDUCTION; UMBILICAL ARTERIES;

EID: 33645506661     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200603010-00006     Document Type: Article

References (32)

1. Okamoto K, Kato S, Arima N, Fujii T, Morimatsu M, Imaizumi T. Cyclin-dependent kinase inhibitor, p21Waf1, regulates vascular smooth muscle cell hypertrophy. Hypertens Res 2004; 27: 283-291.
2. Yoshida T, Hoofnagle MH, Owens GK. Myocardin and Prx1 contribute to angiotensin II-induced expression of smooth muscle alpha-actin. Circ Res 2004; 94: 1075-1082.
3. Eto H, Biro S, Miyata M, Kaieda H, Obata H, Kihara T, et al. Angiotensin II type 1 receptor participates in extracellular matrix production in the late stage of remodeling after vascular injury. Cardiovasc Res 2003; 59: 200-211.
4. Hollenbeck ST, Itoh H, Louie O, Faries PL, Liu B, Kent KC. Type I collagen synergistically enhances PDGF-induced smooth muscle cell proliferation through pp60src-dependent crosstalk between the alpha2beta1 integrin and PDGFbeta receptor. Biochem Biophys Res Commun 2004; 325: 328-323.
5. Rekhter MD, Zhang K, Narayanan AS, Phan S, Schork MA, Gordon D. Type I collagen gene expression in human atherosclerosis. Am J Pathol 1993; 143: 1634-1648.
6. Chan AK, Kalmes A, Hawkins S, Daum G, Clowes AW. Blockade of the epidermal growth factor receptor decreases intimal hyperplasia in balloon-injured rat carotid artery. J Vasc Surg 2003; 37: 644-649
7. Liu G, Wang H, Ou D, Liao D. Endothelin-1, an important mitogen of smooth muscle cells of spontaneously hypertensive rats. Chin Med J 2002; 115: 750-752.
8. Liu XM, Reyna SV, Ensenat D, Peyton KJ, Wang H, Schafer AI, et al. Platelet-derived growth factor stimulates LAT1 gene expression in vascular smooth muscle: Role in cell growth. FASEB J 2004; 18: 768-770.
9. Tang JB, Xu Y, Ding F, Wang ST. Tendon healing in vitro: promotion of collagen gene expression by bFGF with NF-kappaB gene activation. Hand Surg 2003; 28: 215-220.
10. Sanz-Rosa D, Oubina MP, Cediel E, de Las Heras N, Vegazo O, Jimenez J, et al. Effect of AT1 receptor antagonism on vascular and circulating inflammatory mediators in SHR: role of NF-kappaB/IkappaB system. Am J Physiol Heart Circ Physiol 2005; 288: H111-H115.
11. Woods M, Wood EG, Bardswell SC, Bishop-Bailey D, Barker S, Wort SJ, et al. Role for nuclear factor-kappaB and signal transducer and activator of transcription 1/interferon regulatory factor-1 in cytokine-induced endothelin-1 release in human vascular smooth muscle cells. Mol Pharmacol 2003; 64: 923-931.
12. Park JY, Kim YM, Song HS, Park KY, Kim YM, Kim MS, et al. Oleic acid induces endothelin-1 expression through activation of protein kinase C and NF-kappa B. Biochem Biophys Res Commun 2003; 303: 891-895.
13. Baeuerle PA, Baltimore D. I kappa B: a specific inhibitor of the NF-kappa B transcription factor. Science 1988; 242: 540-546.
14. Satoh A, Gukovskaya AS, Nieto JM, Cheng JH, Gukovsky I, Reeve JR Jr, et al. PKC-delta and -epsilon regulate NF-kappaB activation induced by cholecystokinin and TNF-alpha in pancreatic acinar cells. Am J Physiol Gastrointest Liver Physiol 2004; 287: G582-591.
15. Schulze-Osthoff K, Ferrari D, Riehemann K, Wesselborg S. Regulation of NF-kappa B activation by MAP kinase cascades. Immunobiology 1997; 198: 35-49.
16. National Institutes of Health. National high blood pressure education program working group on high blood pressure in pregnancy. NIH Publication No.00-3029 (orignally printed in 1990. revised in July 2000).
17. Koyama N, Harada K, Yamamoto A, Morisaki N, Saito Y, Yoshida S. Purification and characterization of an autocrine migration factor for vascular smooth muscle cells (SMC), SMC-derived migration factor. J Biol Chem 1993; 268: 13301-13308.
18. Schreiber E, Matthias P, Muller MM, Schaffner W. Rapid detection of octamer binding proteins with mini-extracts, prepared from a small number of cells. Nucleis Acids Res 1989; 17: 6419.
19. Chomczynski P, Sacchi N. Single-step method of RNA-isolation by acid guanidinium thiocyanate- phenolchloroform extraction. Anal Biochem 1987; 162: 156-159.
20. Yang Z, Zhang L, Li D, Qiu F. Pathological morphology alteration of the splanchnic vascular wall in portal hypertensive patients. Chin Med J 2002; 115: 559-562.
21. Karim MA, Miller DD, Farrar MA, Eleftheriades E, Reddy BH, Breland CM, et al. Histomorphometric and biochemical correlates of arterial procollagen gene expression during vascular repair after experimental angioplasty. Circulation 1995; 91: 2049-2057.
22. Li S, Van Den Diepstraten C, D'Souza SJ, Chan BM, Pickering JG Vascular smooth muscle cells orchestrate the assembly of type I collagen via alpha2beta1 integrin, RhoA, and fibronectin polymerization. Am J Pathol 2003; 163: 1045-1056.
23. Pickering JG, Ford CM, Tang B, Chow LH. Coordinated effects of fibroblast growth factor-2 on expression of fibrillar collagens, matrix metalloproteinases, and tissue inhibitors of matrix metalloproteinases by human vascular smooth muscle cells. Evidence for repressed collagen production and activated degradative capacity. Arterioscler Thromb Vasc Biol 1997; 17: 475-482.
24. Zhang HP, Xu YJ, Zhang ZX, Ni W, Chen SX. Effect of protein kinase C-nuclear factor-kappa B signal transduction pathway on proliferation and expression of vascular endothelial growth factor in human pulmonary artery smooth muscle cells. Chin J Respir Tuberc (Chin) 2004; 27: 218-223.
25. Haller H, Maasch C, Lindschau C, Brachmann M, Buchner K, Luft FC. Intracellular targeting and protein kinase C in vascular smooth muscle cells: specific effects of different membrane-bound receptors. Acta Physiol Scand 1998; 164: 599-609.
26. Wellner M, Maasch C, Kupprion C, Lindschau C, Luft FC, Haller H. The proliferative effect of vascular endothelial growth factor requires protein kinase C-alpha and protein kinase C-zeta. Arterioscler Thromb Vesc Biol 1999; 19: 178-185.
27. Yamauchi N, Harada T, Taniguchi F, Yoshida S, Iwabe T, Terakawa N. Tumor necrosis factor-alpha induced the release of interleukin-6 from endometriotic stromal cells by the nuclear factor-kappaB and mitogen-activated protein kinase pathways. Fertil Steril 2004; 82 (Suppl 3): 1023-1028.
28. Schonwasser DC, Marais RM, Marshall CJ, Parker PJ. Activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by conventional, novel, and atypical protein kinase C isotypes. Mol Cell Biol 1998; 18: 790-798.
29. Yemeni KK, Bai W, Khan BV, Medford RM, Natarajan R. Hyperglycemia-induced activation of nuclear transcription factor kappaB in vascular smooth muscle cells. Diabetes 1999; 48: 855-864.
30. Minami T, Abid MR, Zhang J, King G, Kodama T, Aird WC. Thrombin stimulation of vascular adhesion molecule-1 in endothelial cells is mediated by protein kinase C (PKC)-delta-NF-kappa B and PKC-zeta-GATA signaling pathways. J Biol Chem 2003; 278: 6976-6984.
31. Rahman A, True AL, Anwar KN, Ye RD, Voyno-Yasenetskaya TA, Malik AB. Galpha(q) and Gbetagamma regulate PAR-1 signaling of thrombinnduced NF-kappaB activation and ICAM-1 transcription in endothelial cells. Circ Res 2002; 91: 398-405.
32. Zhao Q, Lee FS. Mitogen-activated protein kinase/ERK kinase kinases 2 and 3 activate nuclear factor-kappaB through IkappaB kinase-alpha and IkappaB kinase-beta. J Biol Chem 1999; 274: 8355-8358.